Wellspring Capital Management, a private equity firm headquartered in New York, agreed to acquire Pentec Health, a provider of patient-specific sterile compounding. Financial terms were not disclosed. "I am delighted to announce our new investment partnership with Wellspring Capital. Wellspring has demonstrated its healthcare investment mastery for many years, and the confidence that Alex, Nash, and the team at Wellspring has placed in Pentec is both an affirmation of our strategy and an acknowledgment that we have one of the most dynamic national home infusion platforms, led by an extraordinarily talented management team," Joseph Cosgrove, Pentec Chairman, President, and CEO.